Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon | NSE | Healthcare | Biotechnology & Medical Research | ₹443.54B | 28.1x | 0.1 | ₹370.25 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.8% Downside | Upgrade to Pro+ | |
Biocon | BSE | Healthcare | Biotechnology & Medical Research | ₹443.30B | 28.1x | 0.1 | ₹370.25 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.1% Downside | Upgrade to Pro+ | |
Syngene International Ltd BO | BSE | Healthcare | Biotechnology & Medical Research | ₹355.47B | 72.7x | 36.07 | ₹886.80 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.4% Downside | Upgrade to Pro+ | |
Syngene International Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹355.47B | 72.3x | 36.07 | ₹885.90 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.2% Downside | Upgrade to Pro+ | |
Vimta Labs Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹12.17B | 29.6x | -2.1 | ₹549.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vimta Labs | BSE | Healthcare | Biotechnology & Medical Research | ₹12.17B | 29.5x | -2.1 | ₹548 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shree Ganesh Remedies | BSE | Healthcare | Biotechnology & Medical Research | ₹10.58B | 37x | 0.9 | ₹818.55 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Indo Us Bio-Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹6.01B | 66.4x | 8.23 | ₹300 | 7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹2.93B | -2.5x | 0.12 | ₹20.03 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions | BSE | Healthcare | Biotechnology & Medical Research | ₹2.93B | -2.5x | 0.12 | ₹20.07 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jeevan Scientific Technology | BSE | Healthcare | Biotechnology & Medical Research | ₹855.59M | -120.4x | -1.61 | ₹55.27 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivo Bio Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹591.22M | 23.5x | -2.36 | ₹39.67 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene Biotek | BSE | Healthcare | Biotechnology & Medical Research | ₹568.28M | -183.5x | -1.96 | ₹7.87 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vanta Bioscience | BSE | Healthcare | Biotechnology & Medical Research | ₹323.36M | -14x | -0.19 | ₹51.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chemo Pharma Laboratories | BSE | Healthcare | Biotechnology & Medical Research | ₹103.52M | 9.8x | 0.69 | ₹69.01 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |